RANDOMISED, OPEN-LABEL STUDY TO EVALUATE 2 INTRAVITREAL AFLIBERCEPT TREAT-AND-EXTEND DOSING REGIMENS IN WET AGE-RELATED MACULAR DEGENERATION: 52-WEEK OUTCOMES FROM ALTAIR
PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM
THE CLINICAL USE OF TOPICAL HYPERTONIC SALINE EYE DROPS IN A TERTIARY REFERRAL EYE CARE CENTRE IN SYDNEY, AUSTRALIA
N-ACETYL-CYSTEINE IN OCULAR THERAPY: A REVIEW OF THE LITERATURE
IRRITABLE BOWEL SYNDROME IS A RISK FACTOR FOR GLAUCOMA; ANALYSIS OF TWO EUROPEAN POPULATION-BASED COHORT STUDIES
RANZCO: The Case for Inclusion